莫诺帕制药 MNPR
$71.42 +$4.20 (+6.25%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $73.00 +2.21%
开盘$68.02
昨收$67.22
当日区间$67.31 – $72.25
成交量94.2K
市值$479.38M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例109.0%-0.28 个百分点，较上季度
持仓机构数119+5 ，较上季度
内部人近期交易30次买入 / 20次卖出净买入
空头持仓比例16.81% 占流通股回补天数 7.1 · 截至 15 Oct 2026
卖空成交量占比17.5%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$630.3K（7个净流入日，13个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有50.8%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从15.90%升至16.81%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Rafferty Asset Management, LLC | Mutual Fund | 2026/Q3 | +5,959 | 0.1% |
| Chandler Robinson | Individual/Insider | 2026/Q3 | +5,457 | 2.5% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +5,980 | 0.1% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +157,423 | 2.3% |
| Candriam, Société En Commandite Par Actions | Mutual Fund | 2026/Q3 | +143,339 | 2.1% |
| TCG Crossover Management, LLC | VC/PE Fund | 2026/Q3 | +71,224 | 3.0% |
| Longaeva Partners L.P. | Mutual Fund | 2026/Q3 | +55,834 | 0.8% |
| Driehaus Capital Management LLC | Mutual Fund | 2026/Q3 | +50,884 | 1.3% |
| Ikarian Capital, LLC | Hedge Fund | 2026/Q3 | +47,861 | 0.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +32,252 | 5.2% |
| StemPoint Capital LP | Hedge Fund | 2026/Q3 | +30,125 | 0.4% |
| Neuberger Berman Investment Advisers LLC | Mutual Fund | 2026/Q3 | +22,647 | 0.8% |
| Boothbay Fund Management, LLC | Hedge Fund | 2026/Q3 | +14,689 | 0.2% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +12,660 | 1.7% |
| Ishara Investments, L.P. | Hedge Fund | 2026/Q3 | +12,300 | 0.2% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 19 Oct 2026 | Chandler Robinson | Chief Executive Officer | Sale to Issuer | -597 | $92.59 | 166,942 |
| 30 Sep 2026 | Christopher Starr | Co-Founder & Independent Executive Chairman of the Board | Derivative Exercise and Sale | -8,400 | $79.67 | 15,053 |
| 29 Sep 2026 | Andrew Cittadine | Chief Operating Officer | Derivative Exercise and Sale | -1,944 | $79.67 | 58,054 |
| 29 Sep 2026 | Andrew Cittadine | Chief Operating Officer | Derivative Exercise and Retained | +2,440 | – | 58,054 |
| 29 Sep 2026 | Chandler Robinson | Chief Executive Officer | Derivative Exercise and Sale | -4,344 | $79.67 | 167,539 |
| 29 Sep 2026 | Chandler Robinson | Chief Executive Officer | Derivative Exercise and Retained | +5,457 | – | 167,539 |
| 29 Sep 2026 | Quan Vu | CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer | Derivative Exercise and Sale | -180 | $79.67 | 2,655 |
| 29 Sep 2026 | Quan Vu | CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer | Derivative Exercise and Retained | +434 | – | 2,655 |
| 23 Sep 2026 | Chandler Robinson | Chief Executive Officer | Derivative Exercise and Sale | -29,056 | $89.79 | 162,082 |
| 25 Aug 2026 | Patrice Rioux | Acting Chief Medical Officer | Derivative Exercise and Sale | -1 | $111.26 | 5,065 |
| 25 Aug 2026 | Patrice Rioux | Acting Chief Medical Officer | Other Derivative Acquisition | +1,380 | $0.01 | – |
| 25 Aug 2026 | Patrice Rioux | Acting Chief Medical Officer | Derivative Exercise and Retained | +1,379 | $0.01 | 5,065 |
| 25 Aug 2026 | Kim Tsuchimoto | Director | Automatic Disposition | -4,090 | $113.84 | 11,486 |
| 25 Aug 2026 | Kim Tsuchimoto | Director | Derivative Exercise and Sale | -4,090 | $113.84 | 11,486 |
| 25 Aug 2026 | Kim Tsuchimoto | Director | Other Derivative Acquisition | +4,090 | $30.00 | 8,140 |
| 24 Aug 2026 | Raymond Anderson | Independent Director | Derivative Exercise and Sale | -3,142 | $113.05 | 5,373 |
| 24 Aug 2026 | Raymond Anderson | Independent Director | Other Derivative Acquisition | +3,142 | $30.00 | 3,480 |
| 7 Jul 2026 | Arthur Klausner | Former Independent Director | Intent to Sell (Form 144) | -5,000 | – | – |
| 29 Jun 2026 | Andrew Cittadine | Chief Operating Officer | Derivative Exercise and Sale | -2,309 | $92.59 | 55,614 |
| 29 Jun 2026 | Andrew Cittadine | Chief Operating Officer | Derivative Exercise and Retained | +2,945 | – | 55,614 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 1,128,617 | 16.8% | 7.1 |
| 30 Sep 2026 | 1,086,279 | 16.2% | 6.0 |
| 15 Sep 2026 | 844,226 | 12.6% | 7.2 |
| 31 Aug 2026 | 852,425 | 12.7% | 4.5 |
| 14 Aug 2026 | 887,188 | 13.2% | 3.5 |
| 31 Jul 2026 | 1,065,108 | 15.9% | 3.4 |
暂无评论——快来第一个聊聊 MNPR。
登录后参与讨论。